Qube Research & Technologies (QRT)’s Axsome Therapeutics AXSM Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio AXSM Stock Details AXSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$104M	Buy	426,336 +91,002	+27%	+$19.7M	0.1%	276
2026 Q1	$56.7M	Buy	335,334 +9,894	+3%	+$1.71M	0.06%	385
2025 Q4	$59.4M	Sell	325,440 -186	-0.1%	-$26K	0.06%	418
2025 Q3	$39.5M	Sell	325,626 -65,991	-17%	-$7.43M	0.04%	575
2025 Q2	$40.9M	Buy	391,617 +109,241	+39%	+$11.6M	0.04%	549
2025 Q1	$32.9M	Buy	282,376 +126,465	+81%	+$14.4M	0.04%	545
2024 Q4	$13.2M	Buy	155,911 +125,541	+413%	+$11.5M	0.02%	934
2024 Q3	$2.73M	Buy	+30,370	New	+$2.65M	﹤0.01%	1641
2024 Q2	–	Sell	-1,696	Closed	-$135K	–	3808
2024 Q1	$135K	Buy	+1,696	New	+$142K	﹤0.01%	3193
2023 Q1	–	Sell	-23,786	Closed	-$1.83M	–	2537
2022 Q4	$1.83M	Sell	23,786 -98,024	-80%	-$5.86M	0.01%	973
2022 Q3	$5.43M	Buy	+121,810	New	+$6.09M	0.03%	594

Other funds holding AXSM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Qube Research & Technologies (QRT)'s AXSM Position: Q2 2026 in Review

Qube Research & Technologies (QRT) increased its Axsome Therapeutics (AXSM) stake by 27% in Q2 2026, buying an estimated $19.7M and bringing the position to 426,336 shares worth $104M. The position accounts for 0.1% of the portfolio, ranked #276.

Qube Research & Technologies (QRT) first reported a position in AXSM in Q3 2022 and has held it in 11 quarters since. 506 funds tracked by Wall St. Rank hold AXSM as of Q2 2026.

Qube Research & Technologies (QRT) held 426,336 shares of Axsome Therapeutics worth $104M as of Q2 2026.
Qube Research & Technologies (QRT) bought 91,002 Axsome Therapeutics shares in Q2 2026, an estimated $19.7M.
Axsome Therapeutics made up 0.1% of Qube Research & Technologies (QRT)'s portfolio in Q2 2026, its #276 holding.
Qube Research & Technologies (QRT) first reported a position in Axsome Therapeutics in Q3 2022 and has held it in 11 quarters since.
506 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q2 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2026, filed 14 Aug 2026.